{{Rsnum
|rsid=11218342
|Gene=SORL1
|Chromosome=11
|position=121563719
|Orientation=plus
|GMAF=0.04775
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=SORL1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.0 | 5.4 | 94.6
| HCB | 0.0 | 6.7 | 93.3
| JPT | 1.8 | 28.6 | 69.6
| YRI | 0.0 | 10.9 | 89.1
| ASW | 1.8 | 17.5 | 80.7
| CHB | 0.0 | 6.7 | 93.3
| CHD | 1.0 | 8.7 | 90.4
| GIH | 0.0 | 4.0 | 96.0
| LWK | 0.0 | 20.9 | 79.1
| MEX | 0.0 | 7.0 | 93.0
| MKK | 1.3 | 13.5 | 85.3
| TSI | 1.0 | 2.9 | 96.1
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs11218342
|Name_s=
|Gene_s=SORL1
|Feature=
|Evidence=PubMed ID:17553421; PubMed ID:19118814
|Annotation=This variant is nominally associated with late-onset Alzheimer disease (LOAD) in 2 GWAS studies.
|Drugs=
|Drug Classes=
|Diseases=Alzheimer Disease
|Curation Level=Curated
|PharmGKB Accession ID=PA162363855
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs11218342
|overall_frequency_n=9
|overall_frequency_d=128
|overall_frequency=0.0703125
|n_genomes=9
|n_genomes_annotated=0
|n_haplomes=9
|n_articles=0
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=2
|webscore=N
|n_web_uneval=5
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}